COLLEEN SIMON: Open Payments
NPI 1972266252 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 2 payments from 2 companies in 2025. Trend: 2023 $3,057 · 2024 $0 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $120 |
| Neurocrine BioSciences, Inc. | 1 | $118 |
Products named: ZEPBOUND, INGREZZA.
Industry payments across MI — which companies pay providers there.
